Lorlatinib: A Targeted Therapy for ALK-Positive Lung Cancer Lorlatinib is a next-generation tyrosine kinase inhibitor (TKI) designed to treat ALK-positive non-small cell lung cancer (NSCLC). Approved by the FDA and…
Ibrutinib: Uses, Benefits, Side Effects, and More Ibrutinib is an oral medication used in the treatment of various types of blood cancers. It is a targeted therapy known as a…
Gilteritinib: Targeted Therapy for FLT3-Mutated AML Gilteritinib is a breakthrough oral medication used in the treatment of acute myeloid leukemia (AML), specifically for patients with a FLT3 gene mutation. As…
Dacomitinib: Uses, Dosage, Side Effects & More Dacomitinib is a prescription medication used for the treatment of non-small cell lung cancer (NSCLC). As a targeted therapy, it works by inhibiting…
Reviews
There are no reviews yet.